Abstract
Antipneumococcus serums from rabbits have now been accepted by the Council for types I, II, III, IV, V, VII, VIII and XIV.1An evaluation of the other types of antipneumococcus serums, which for convenience will be called the "higher types,"2involves a consideration of the following problems: (1) the present status of the pneumococcus types, particularly as it concerns serologically related types; (2) the relation of the higher types to disease in general and to pneumonia in particular; (3) the efficacy of antipneumococcus rabbit serums in the treatment of the pneumonias associated with pneumococci of these types; (4) the status of specific antiserum therapy for pneumonia in relation to the use of effective sulfonamide compounds (a) as a supplement or (b) as a substitute for the drugs, and (5) the use of serums in the treatment of focal pneumococcic infections, particularly meningitis and peritonitis. It may be stated

This publication has 0 references indexed in Scilit: